NCT00320398View on ClinicalTrials.gov

Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium)

PHASE3CompletedINTERVENTIONAL

Enrollment

114

Participants

Timeline

Start Date

January 30, 2006

Primary Completion Date

July 18, 2006

Study Completion Date

July 18, 2006

Conditions

Thrombosis, Venous

Interventions

DRUG

Fondaparinux

Trial Locations (1)

Unknown

GSK Investigational Site

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY